Acura Pharmaceuticals Inc. (Nasdaq:ACUR) announced that the company has been issued U.S. Patent No. 7,981,439 by the United States Patent and Trademark Office.

Acura Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and manufacture of pharmaceutical product candidates utilizing its proprietary Aversion and Impede technologies.

Read the full article and the disclaimer at: http://drstockpick.com/?p=22271